PCSK9 and cardiovascular disorder: PCSK9 also contributes to the development of cardiovascular disease in a LDLR-dependent or LDLR-independent manner, and is involved in the promotion of inflammation, plaque development, and thrombosis (Luquero et al., 2021; D’Onofrio et al., 2023).